Related Experiment Videos
[HDL cholesterol in patients with peripheral arteriosclerotic occlusive disease]
Insights
High-density lipoprotein cholesterol (HDL-C) levels decrease with increasing peripheral arteriosclerotic obstructive disease severity. Patients with hyperlipoproteinemia also exhibit lower HDL-C concentrations.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Clinical Chemistry
Context:
- Peripheral arteriosclerotic obstructive disease (PAOD) affects lower extremities.
- HDL-cholesterol (HDL-C) is a key lipid marker.
- Patient cohort included 40 controls and 73 PAOD males.
Purpose:
- To investigate HDL-cholesterol levels in male patients with PAOD.
- To assess the relationship between PAOD severity and HDL-C.
- To evaluate the impact of hyperlipoproteinemia on HDL-C in PAOD.
Summary:
- No overall reduction in HDL-C concentration was proven in PAOD patients.
- HDL-C levels significantly decrease with increasing PAOD severity.
- Drug therapies for PAOD showed varied effects on HDL-C.
- Hyperlipoproteinemia patients displayed lower HDL-C than those with normal lipid profiles.
Impact:
- Highlights the inverse correlation between PAOD progression and HDL-C.
- Suggests HDL-C as a potential biomarker for PAOD severity.
- Informs therapeutic strategies by indicating differential drug effects on HDL-C.
Abstract:
The HDL-cholesterol level in the blood serum was determined in 40 male control persons and 73 male patients with peripheral arteriosclerotic obstructive disease of the lower extremities. A reduction of the HDL concentration as a whole could not be proved. The influence of the various drugs applied to the therapy of the arteriosclerotic obstructive disease on the HDL-cholesterol level in the blood serum is different. With increasing severity of the arterial obstructive disease the HDL level significantly decreases. Patients with hyperlipoproteinaemias show lower HDL concentrations than test persons with inconspicuous serum lipid concentrations.